Endothelial function in women of the Kronos Early Estrogen Prevention Study

References

• Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243–52
   PubMed Web of Science ®Google Scholar
• Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med 1991;325:226–30
   PubMed Web of Science ®Google Scholar
• Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006;47:S21–9
   PubMed Web of Science ®Google Scholar
• Michos ED, Nasir K, Braunstein JB, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 2006;184:201–6
   PubMed Web of Science ®Google Scholar
• Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2007;167:2437–42
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Antoniades C, Stefanadis C. Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart 2005;91:553–8
   PubMed Web of Science ®Google Scholar
• Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008;117:2467–74
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004;44:2137–41
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468–74
   PubMed Web of Science ®Google Scholar
• Celermajer DS. Reliable endothelial function testing: at our fingertips? Circulation 2008;117:2428–30
   PubMed Web of Science ®Google Scholar
• Lieberman EH, Gerhard MD, Uehata A, et al. Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease. Am J Cardiol 1996;78:1210–14
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Sugiyama S, Sugamura K, et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol 2010;55:1688–96
   PubMed Web of Science ®Google Scholar
• Hamburg N, Charbonneau F, Gerhard-Herman M, Ganz P, Creager MA. Comparison of endothelial function in young men and women with a family history of premature coronary artery disease. Am J Cardiol 2004;94:783–5
   PubMed Web of Science ®Google Scholar
• Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 2012;97:4692–700
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47–63
   PubMed Web of Science ®Google Scholar
• Bush TL, Cowan LD, Barrett-Connor E, et al. Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA 1983;249:903–6
   PubMed Web of Science ®Google Scholar
• Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102–9
   PubMed Web of Science ®Google Scholar
• Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol 1991;164:489–94
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933–41
   PubMed Web of Science ®Google Scholar
• Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6–12
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009;2:228–39
   PubMed Web of Science ®Google Scholar
• Clarkson TB, Appt SE. Controversies about HRT – lessons from monkey models. Maturitas 2005;51:64–74
   PubMed Web of Science ®Google Scholar
• Vita J, Keaney JF Jr. Hormone replacement therapy and endothelial function. Arterioscler Thromb Vac Biol 2001;21:1867–9
   PubMed Web of Science ®Google Scholar
• Miller VM, Mulvagh SL. Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci 2007;28:263–70
   PubMed Web of Science ®Google Scholar
• Holm P, Andersen HL, Andersen MR, Erhardtsen E, Stender S. The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium: A time course study in cholesterol-clamped rabbits. Circulation 1999;100:1727–33
   PubMed Web of Science ®Google Scholar
• Schierbeck L, Rejnmark L, Tofteng C, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial. BMJ 2012;345:e6409
   PubMed Web of Science ®Google Scholar
• The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause 2012;19:257–71
   PubMed Web of Science ®Google Scholar
• Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. Circulation 2011;123:1243–62
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Gass ML, Haines CJ, et al. Global Consensus Statement on menopausal hormone therapy. Climacteric 2013;16: 201–4
   PubMed Web of Science ®Google Scholar
• Mulvagh SL, Behrenbeck T, Lahr BA, et al. Endothelial function and cardiovascular risk stratification in menopausal women. Climacteric 2010;13:45–54
   PubMed Web of Science ®Google Scholar
• Harman SM, Brinton EA, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005;8:3–12
   PubMed Web of Science ®Google Scholar
• Farr JN, Khosla S, Miyabara Y, Miller VM, Kearns AE. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab 2013;98:E249–57
   PubMed Web of Science ®Google Scholar
• Gerhard MD, Tawakol A, Haley EA, et al. Long-term estradiol therapy with or without progesterone improves endothelium-dependent vasodilation in postmenopausal women. Circulation 1996;94:I–279
   Google Scholar
• Best PJM, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998;128:285–8
   PubMed Web of Science ®Google Scholar
• Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234–8
   PubMed Web of Science ®Google Scholar
• Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: A randomized trial. Ann Intern Med 2014;161:249–60
   PubMed Web of Science ®Google Scholar
• O’Rourke S, Vanhoutte PM, Miller VM. Vascular pharmacology. In Creager MA, Dzau V, Loscalzo J, eds. Vascular Medicine, A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier, 2006:71–100
   Google Scholar
• Onkelinx S, Cornelissen V, Goetschalckx K, Thomaes T, Verhamme P, Vanhees L. Reproducibility of different methods to measure the endothelial function. Vasc Med 2012;17:79–84
   PubMed Web of Science ®Google Scholar
• Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med 2007;12:13–16
   PubMed Web of Science ®Google Scholar
• Heffernan KS, Karas RH, Mooney PJ, Patel AR, Kuvin JT. Pulse wave amplitude is associated with brachial artery diameter: implications for gender differences in microvascular function. Vasc Med 2010;15:39–45
   PubMed Web of Science ®Google Scholar